Grants per year
- 1,225 - 1,250 out of 7,255 results
Search results
-
Active
Prot #BMT CTN 1506/2215-CL-0304: A Multi-Center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/ITD AML
Frankfurt, O.
National Marrow Donor Program, Astellas Pharma Global Development, Inc.
4/12/18 → 4/12/25
Project: Research project
-
¿CONQUER Registry
Correia, C. S. (PD/PI), Correia, C. S. (PD/PI), Fantus, S. (PD/PI), Fantus, S. (PD/PI), Perlman, H. R. (PD/PI) & Perlman, H. R. (PD/PI)
Scleroderma Research Foundation
3/10/18 → 3/9/25
Project: Research project
-
Prot #ML28897/PRO 02: MY PATHWAY: An Open-Label Phase IIa Study Evaluating Trastuzumab/Pertuzumab, Erlotinib, Vemurafenib/Cobimetinib, Vismodegib, Alectinib, And Atezolizumab In Patients Who Have Advanced Solid Tumors With Mutations Or Gene Expression Abn
Villaflor, V. M.
Sarah Cannon Research Institute, Genentech, Inc
11/27/17 → 3/31/26
Project: Research project
-
Prot #HCRN GU16-260: NU G17U11: Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma (BMS CA209-669)
Sosman, J. A. (PD/PI)
Hoosier Cancer Research Network, Inc., Georgetown University
11/21/17 → 11/21/26
Project: Research project
-
Prot #CA209-914: A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
Sosman, J. A. (PD/PI)
10/9/17 → 10/9/26
Project: Research project
-
Chicago Metropolitan Asthma Consortium for severe/exacerbation-prone asthma
Rosenberg, S. R. (PD/PI), Rosenberg, S. R. (PD/PI), Smith, L. J. (PD/PI), Kalhan, R. (Co-Investigator) & Peters, A. T. (Co-Investigator)
The University of Chicago, National Heart, Lung, and Blood Institute
9/23/17 → 6/30/25
Project: Research project
-
Prot #MDV3100-13: A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy
Morgans, A. K.
Quintiles, Inc., Medivation, Inc.
8/25/17 → 8/25/26
Project: Research project
-
Transformative Research in Diabetic Nephropathy (TRIDENT)
Isakova, T. (PD/PI)
University of Pennsylvania, Boehringer Ingelheim Pharmaceuticals, Inc.
8/24/17 → 8/31/27
Project: Research project
-
Prot #NU 16H08: Phase II study of PET-directed frontline therapy with pembrolizumab and AVD for patients with classical Hodgkin lymphoma
Winter, J. N. (PD/PI)
Merck Sharp & Dohme Corporation
8/10/17 → 8/10/26
Project: Research project
-
Protocol# 1601: REDUCE II - REDUCE LAP-HF RANDOMIZED TRIAL II: A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure
Flaherty, J. D. (PD/PI) & Ricciardi, M. J. (Other)
Harvard Clinical Research Institute, Corvia Medical, Inc.
6/6/17 → 6/6/26
Project: Research project
-
SJM-CIP-10114: AMULET IDE - Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
Knight, B. P. (PD/PI)
5/19/17 → 5/19/26
Project: Research project
-
Therapy Consortium Award
Hussain, M. (PD/PI) & Hussain, M. (PD/PI)
5/1/17 → 12/21/25
Project: Research project
-
Prot #NU 16H07: Phase II Trial of Pembrolizumab in Combination with ICE Salvage Chemotherapy for Relapsed/Refractory Hodgkin Lymphoma
Winter, J. N. (PD/PI)
Merck Sharp & Dohme Corporation
4/3/17 → 4/3/26
Project: Research project
-
Prot #NU 16B08: Phase II Study of Pembrolizumab and Capecitabine for Advanced Triple Negative and Hormone-Refractory Breast Cancer
Gradishar, W. J. (PD/PI) & Jain, S. (PD/PI)
Merck Sharp & Dohme Corporation
1/20/17 → 1/20/26
Project: Research project
-
CBC_NU DF-021 PI-Daniel Batlle: Novel Form of Short ACE2 for Treatment of Scleroderma Kidney in a Mouse Model for the amount of $36,980 for period 4/1/2023 - 9/30/2023
Batlle, D. (Other) & Batlle, D. (Other)
Searle Funds at The Chicago Community Trust
1/1/17 → 12/31/25
Project: Research project
-
Study# 2013-05C: Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance after Mitral Valve Replacement with Transcatheter Device
Davidson, C. J. (PD/PI)
12/6/16 → 12/6/27
Project: Research project
-
Prot #c16-168: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects
Hussain, M. (PD/PI)
Prostate Cancer Clinical Trials Consortium, LLC, AstraZeneca Pharmaceuticals LP
11/11/16 → 11/11/25
Project: Research project
-
Prot#B3461045: A Phase 3 Multicenter, Open-Label Study to Evaluate the Safety of Daily Oral Dosing of Tafamidis Meglumine (PF-06291826-83) 20 mg or 80 mg (or Tafamidis(06291826-00) 61 mg) in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM)
Shah, S. J. (PD/PI)
PPD Investigator Services, LLC, Pfizer Inc.
7/27/16 → 7/27/25
Project: Research project
-
Prot #CP-MGAH22-04: A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Two Prior Anti-HER2 Therapies and Require Systemic Treatm
Gradishar, W. J. (PD/PI)
6/21/16 → 6/21/25
Project: Research project
-
Prot #ACE-CL-208: A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
Ma, S. (PD/PI)
INC Research, LLC, Acerta Pharma B.V.
5/15/16 → 5/15/25
Project: Research project